Mangoceuticals Statistics

Total Valuation

Mangoceuticals has a market cap or net worth of $20.05 million. The enterprise value is $20.02 million.

Market Cap	20.05M
Enterprise Value	20.02M

Important Dates

The next estimated earnings date is Monday, August 18, 2025, after market close.

Earnings Date	Aug 18, 2025
Ex-Dividend Date	n/a

Share Statistics

Mangoceuticals has 11.79 million shares outstanding. The number of shares has increased by 113.52% in one year.

Current Share Class	11.79M
Shares Outstanding	11.79M
Shares Change (YoY)	+113.52%
Shares Change (QoQ)	+75.26%
Owned by Insiders (%)	17.65%
Owned by Institutions (%)	2.25%
Float	8.75M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	9.09
Forward PS	n/a
PB Ratio	0.60
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	39.17
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 0.12, with a Debt / Equity ratio of 0.00.

Current Ratio	0.12
Quick Ratio	0.05
Debt / Equity	0.00
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-689.73

Financial Efficiency

Return on equity (ROE) is -115.89% and return on invested capital (ROIC) is -60.45%.

Return on Equity (ROE)	-115.89%
Return on Assets (ROA)	-53.55%
Return on Invested Capital (ROIC)	-60.45%
Return on Capital Employed (ROCE)	-46.66%
Revenue Per Employee	$170,361
Profits Per Employee	-$4.02M
Employee Count	3
Asset Turnover	0.05
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -62.28% in the last 52 weeks. The beta is 2.42, so Mangoceuticals's price volatility has been higher than the market average.

Beta (5Y)	2.42
52-Week Price Change	-62.28%
50-Day Moving Average	1.76
200-Day Moving Average	2.49
Relative Strength Index (RSI)	49.09
Average Volume (20 Days)	134,815

Short Selling Information

The latest short interest is 279,205, so 2.37% of the outstanding shares have been sold short.

Short Interest	279,205
Short Previous Month	202,063
Short % of Shares Out	2.37%
Short % of Float	3.19%
Short Ratio (days to cover)	1.83

Income Statement

In the last 12 months, Mangoceuticals had revenue of $511,084 and -$12.05 million in losses. Loss per share was -$4.41.

Revenue	511,084
Gross Profit	294,630
Operating Income	-9.45M
Pretax Income	-9.02M
Net Income	-12.05M
EBITDA	-8.31M
EBIT	-9.45M
Loss Per Share	-$4.41

Full Income Statement

Balance Sheet

The company has $76,496 in cash and $47,713 in debt, giving a net cash position of $28,783 or $0.00 per share.

Cash & Cash Equivalents	76,496
Total Debt	47,713
Net Cash	28,783
Net Cash Per Share	$0.00
Equity (Book Value)	20.25M
Book Value Per Share	2.83
Working Capital	-1.33M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-6.15M
Capital Expenditures	n/a
Free Cash Flow	-6.15M
FCF Per Share	-$0.52

Full Cash Flow Statement

Margins

Gross Margin	57.65%
Operating Margin	-1,848.88%
Pretax Margin	-2,187.33%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Mangoceuticals does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-113.52%
Shareholder Yield	-113.52%
Earnings Yield	-60.10%
FCF Yield	-30.66%

Analyst Forecast

Price Target	n/a
Price Target Difference	n/a
Analyst Consensus	n/a
Analyst Count	n/a
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on October 16, 2024. It was a reverse split with a ratio of 1:15.

Last Split Date	Oct 16, 2024
Split Type	Reverse
Split Ratio	1:15

Scores

Mangoceuticals has an Altman Z-Score of 0.67 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	0.67
Piotroski F-Score	2